Populations of Persons Who Must Be Vaccinated with Priority
During a major pandemic of influenza, it would be impossible to vaccinate the entire population. Thus, it is necessary to determine which groups of individuals must be immunized with priority, considering the additional constraints related to the actual situation: to seek to reduce transmission of the virus and to maintain the activity of the community, especially those involved in public services. Another unavoidable factor must also be taken into consideration: the capacity for manufacturing and distributing the vaccine on an emergency basis. Lastly, contingency and planning measures must be made to avoid having to improvise..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
1994 |
---|---|
Erschienen: |
1994 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chippaux, A. [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antigenic shift |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
JST032112750 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | JST032112750 | ||
003 | DE-627 | ||
005 | 20240117213606.0 | ||
007 | cr uuu---uuuuu | ||
008 | 150324s1994 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)JST032112750 | ||
035 | |a (JST)3520994 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chippaux, A. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Populations of Persons Who Must Be Vaccinated with Priority |
264 | 1 | |c 1994 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a During a major pandemic of influenza, it would be impossible to vaccinate the entire population. Thus, it is necessary to determine which groups of individuals must be immunized with priority, considering the additional constraints related to the actual situation: to seek to reduce transmission of the virus and to maintain the activity of the community, especially those involved in public services. Another unavoidable factor must also be taken into consideration: the capacity for manufacturing and distributing the vaccine on an emergency basis. Lastly, contingency and planning measures must be made to avoid having to improvise. | ||
540 | |a Copyright 1994 Kluwer Academic Publishers | ||
650 | 4 | |a Antigenic shift | |
650 | 4 | |a Influenza virus | |
650 | 4 | |a Pandemic | |
650 | 4 | |a Priority vaccination | |
650 | 4 | |a Vaccine | |
650 | 4 | |a Health sciences |x Medical treatment |x Biological therapy |x Immunotherapy |x Immunization |x Vaccination | |
650 | 4 | |a Health sciences |x Health and wellness |x Public health |x Epidemiology |x Disease outbreaks |x Epidemics |x Pandemics | |
650 | 4 | |a Biological sciences |x Biology |x Microbiology |x Microorganisms |x Viruses | |
650 | 4 | |a Biological sciences |x Biology |x Microbiology |x Microorganisms |x Viruses |x RNA viruses |x Orthomyxoviridae | |
650 | 4 | |a Health sciences |x Health and wellness |x Public health |x Epidemiology |x Disease outbreaks |x Epidemics | |
650 | 4 | |a Health sciences |x Medical sciences |x Pharmacology |x Clinical pharmacology |x Pharmacokinetics |x Dosage |x Proceedings 7th European Meeting of Influenza and Its Prevention | |
655 | 4 | |a research-article | |
773 | 1 | 8 | |g volume:10 |g year:1994 |g number:4 |g pages:511-512 |
856 | 4 | 0 | |u https://www.jstor.org/stable/3520994 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_JST | ||
951 | |a AR | ||
952 | |d 10 |j 1994 |e 4 |h 511-512 |